Skip to content
PICO Portalanswers from OpenAlex

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses

PaperCitations, authors & open-access status

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses is a paper indexed in PICO Portal from OpenAlex.

How many citations does Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses have?

PICO Portalcitation count

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses has 150 citations in the OpenAlex counts PICO Portal stores.

When was Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses published?

PICO Portalyear

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses has 2022 year in the PICO Portal index.

What is the open-access status of Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses?

PICO Portaloa status

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses has gold oa status in the PICO Portal index.

What is the DOI of Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses?

PICO Portaldoi

The DOI for Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses is on the source record.

What is the PMID of Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses?

PICO Portalpmid

The PMID for Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses is on the source record.

What is the OpenAlex record for Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses?

PICO Portalopenalex

The OpenAlex for Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial